Search research articles
Contact Us
Filters
Showing results (41-50 of 131) with videos related to
Page
of 14
Sort By:
Human Molecular Genetics
|
January 6, 2017
Identifying new antiepileptic drugs through genomics-based drug repurposing
Nasir Mirza, Greame J Sills, Munir Pirmohamed, et al.
Epilepsy Research
|
June 22, 2002
Influence of cytochrome P450 induction on the pharmacokinetics and pharmacodynamics of remacemide hydrochloride
Graeme J Sills, Sarah Santangeli, Gerard Forrest, et al.
Pharmacogenomics
|
June 5, 2014
Pharmacogenetics of antiepileptic drug-induced hypersensitivity
Katarzyna M Bloch, Graeme J Sills, Munir Pirmohamed, et al.
Seizure
|
December 22, 1999
Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study
G J Sills, E Butler, G G Thompson, et al.
Archives of Disease in Childhood
|
October 23, 2001
Neurological soft signs in mainstream pupils
J M Fellick, A P Thomson, J Sills, et al.
Plos One
|
May 8, 2014
Advantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studies
Karen Tse, Sreekanth Puttachary, Edward Beamer, et al.
Epilepsy Research
|
February 11, 2003
Current limitations of antiepileptic drug therapy: a conference review
C L P Deckers, P Genton, G J Sills, et al.
Seizure
|
May 26, 2004
Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models
Graeme J Sills, Elaine Butler, George G Thompson, et al.
Epilepsia
|
April 16, 2002
Topiramate in patients with learning disability and refractory epilepsy
Kevin Kelly, Linda J Stephen, Graeme J Sills, et al.
European Journal of Pharmacology
|
March 22, 2002
Na(+) channel effects of remacemide and desglycinyl-remacemide in rat cortical synaptosomes
Sarah Santangeli, Graeme J Sills, George G Thompson, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 131) with videos related to
Sort By:
Page
of 14
Human Molecular Genetics
|
January 6, 2017
Identifying new antiepileptic drugs through genomics-based drug repurposing
Nasir Mirza, Greame J Sills, Munir Pirmohamed, et al.
Epilepsy Research
|
June 22, 2002
Influence of cytochrome P450 induction on the pharmacokinetics and pharmacodynamics of remacemide hydrochloride
Graeme J Sills, Sarah Santangeli, Gerard Forrest, et al.
Pharmacogenomics
|
June 5, 2014
Pharmacogenetics of antiepileptic drug-induced hypersensitivity
Katarzyna M Bloch, Graeme J Sills, Munir Pirmohamed, et al.
Seizure
|
December 22, 1999
Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study
G J Sills, E Butler, G G Thompson, et al.
Archives of Disease in Childhood
|
October 23, 2001
Neurological soft signs in mainstream pupils
J M Fellick, A P Thomson, J Sills, et al.
Plos One
|
May 8, 2014
Advantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studies
Karen Tse, Sreekanth Puttachary, Edward Beamer, et al.
Epilepsy Research
|
February 11, 2003
Current limitations of antiepileptic drug therapy: a conference review
C L P Deckers, P Genton, G J Sills, et al.
Seizure
|
May 26, 2004
Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models
Graeme J Sills, Elaine Butler, George G Thompson, et al.
Epilepsia
|
April 16, 2002
Topiramate in patients with learning disability and refractory epilepsy
Kevin Kelly, Linda J Stephen, Graeme J Sills, et al.
European Journal of Pharmacology
|
March 22, 2002
Na(+) channel effects of remacemide and desglycinyl-remacemide in rat cortical synaptosomes
Sarah Santangeli, Graeme J Sills, George G Thompson, et al.
Page
of 14